Emergent BioSolutions Inc. recently announced that the Centers for Disease Control and Prevention has exercised options for the supply of Vaccinia Immune Globulin Intravenous (VIGIV) into the U.S. Strategic National Stockpile. VIGIV is a therapeutic licensed by the U.S. Food and Drug Administration for the treatment of complications due to smallpox vaccination.
The Federal Emergency Management Agency (FEMA) has announced a new Flood Map Service Center (MSC). Use the MSC to find your official flood map, access a range of other flood-hazard products, and take advantage of tools for better understanding flood risk.
Recently, more than 250 emergency managers, first responders, technology entrepreneurs, as well as local, state, and federal officials came to the White House to participate in the Innovation for Disaster Response and Recovery Demo Day. The event was streamed live to more than 1,250 people interested in leveraging technology and innovation to improve disaster preparedness, response, and recovery.
Allegion is celebrating this year's Safe School Week by encouraging its security/architect partners and school end users to be aware of new, untested security and lockdown products that could actually put staff and students at greater risk - some are effective, but some should be avoided.
The KD Analytical National Capital Region office offers a variety of services for facilities and infrastructure protection including CBRNE (chemical, biological, radiological, nuclear, explosive) threat and vulnerability assessment, engineering, and sustainment services.
Significant increases in the use of electronic health records (EHRs) among the nation's physicians and hospitals are detailed in two new studies published by the U.S. Department of Health and Human Services Office of the National Coordinator for Health Information Technology.
The task of training security personnel how to identify and detect many different types of improvised explosive devices (IEDs), gun, and edged-weapon threats has always been difficult due to the inability of using real threats for training. DSA Detection's patented process provides visually correct training aids that respond in screening systems just like the real threat.
The World Health Organization (WHO) released a statement in reference to the International Health Regulations Emergency Committee meeting in regards to the 2014 Ebola virus disease outbreak in West Africa. This statement provides an update on the developments, including measures taken to implement rapid control strategies, as well as existing gaps and challenges in the outbreak response.
Luminex Corporation recently announced that U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) Diagnostics Division is working on rapid diagnostics for the Ebola virus using Luminex xMAP® Technology. Luminex's MAGPIX® system was recently deployed to Africa in support of research efforts to control the current outbreak.
The Centers for Disease Control and Prevention (CDC) is rapidly increasing its ongoing efforts to curb the expanding West African Ebola outbreak and deploying staff to four African nations currently affected. This sustained, agency-wide response will continue until the outbreak is under control, an effort expected to take three to six months.
